CUX1 and neoplasm: More importantly, a comprehensive study by interrogating total 7,651 genome sequences derived from 28 tumor types revealed nonsense and frameshift mutations in CUX1 in 1–5% of tumors and found that CUX1 deficiency can lead to activation of the pro-oncogenic PI3K-AKT signaling (93).